Table 2. Laboratory and Echo Features.
| Laboratory Featuresa | Descriptive Index | Range |
|---|---|---|
| FBSb | 119.185 ± 52.08 | 62-400 |
| Crb | 1.056 ± 0.264 | 0.5-2.2 |
| TGb | 150.343 ± 97.959 | 37-1050 |
| LDLb | 104.644 ± 35.397 | 18-232 |
| HDLb | 40.234 ± 10.559 | 15-111 |
| BUNb | 17.502 ± 6.957 | 6-52 |
| ESRb | 19.462 ± 15.936 | 1-90 |
| HBb | 13.153 ± 1.61 | 8.9-17.6 |
| Kb | 4.231 ± 0.458 | 3.0-6.6 |
| Nab | 140.997 ± 3.808 | 128-156 |
| WBCb | 7562.046 ± 2413.739 | 3700-18000 |
| Lymphb | 32.399 ± 9.973 | 7-60 |
| Neutb | 60.149 ± 10.182 | 32-89 |
| PLTb | 221.488 ±60.796 | 25-742 |
| EFb(%) | 50.788 ± 8.652 | 15-60 |
| Region with RWMAb | 0.620 ± 1.133 | |
| VHDb | ||
| Normal | 116 (38.3%) | |
| Mild | 149 (49.2%) | |
| Moderate | 27 (8.9%) | |
| Severe | 11 (3.6%) |
a Valvular diseases in the current study were classified based on their severity and not on the basis of which valve was diseased. Furthermore, patients with known or predominant valvular heart disease were excluded from the study.
b FBS, fasting blood sugar; C, Creatine; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BUN, blood urea nitrogen; ESR, erythrocyte sedimentation rate; HB, hemoglobin; K, potassium; Na, sodium; WBC, white blood cell; Lymph, lymphocyte; Neut, neutrophil; PLT, platelet; EF, ejection fraction; RWMA, regional wall motion abnormality; VHD, Valvular Heart Disease